Experimental COVID-19 drug trial halted early
NCT ID NCT04661540
Summary
This study tested different doses of an experimental drug called Auxora in hospitalized COVID-19 patients with severe pneumonia requiring breathing machines. The main goal was to see how the drug affected immune cells in the lungs and check if it was safe. The trial was stopped early after enrolling only 10 patients because fewer people were being hospitalized with COVID-19.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.